“lupus” Archives

in
Entry Author Date Location
Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug 06/18/20 Seattle
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others 03/27/20 San Diego
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Novartis & IFM Team Up Again, With Buyout Option for Autoimmune R&D 09/05/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease 02/28/19 San Diego
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours 06/21/18 National
Dutch Biotech Raises $19M to Develop Psoriasis Drug Near San Diego 03/14/18 San Diego
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
Corbus Shares Climb on Early Data For Inflammation Drug 11/14/16 Boston
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More 05/22/15 San Diego
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Houston’s Capital Royalty Evolving in Healthcare Growth Financing 11/19/13 Texas
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets 10/12/11 New York
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
The New Normal for Biotech Startups 01/26/11 Seattle
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners 12/15/10 Boston
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
La Jolla Pharmaceutical Revives With $6M Financing 05/26/10 San Diego
La Jolla Pharmaceutical: Going, Going, But Not Quite Gone 02/26/10 San Diego
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Page 1 of 2 next page »